Renal Cancer Conference is organized by Chicago Urological Society (CUS) and will be held on Feb 07, 2018 at University Club Of Chicago, Chicago, Illinois, United States of America. This CME Conference has been approved for a maximum of 4.75 AMA PRA Category 1 Credits.
Conference Objectives are :
• Describe the genetic aspects to the pathologic characterization of RCC.
• Understand the evolving management of small renal masses.
• Discuss the various treatment modalities appli- cable to RCC and the specific situations in which ablative techniques be considered and situations in which extirpative therapy would be preferred.
• Describe recent advances in adjuvant RCC treat- ment and in which patient populations this therapy would be considered.
• Describe technical considerations and thought process behind the decision to perform partial vs radical nephrectomy in additional to describing when biopsy might also be utilized.
• Understand what patient characteristics are important when considering cytoreductive nephrectomy.
Additional details will be posted as soon as they are available.